Connection
David Irwin to Altitude Sickness
This is a "connection" page, showing publications David Irwin has written about Altitude Sickness.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.216 |
|
|
|
-
Tarshis S, Maltzahn J, Loomis Z, Irwin DC. Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy. Aerosp Med Hum Perform. 2016 Dec 01; 87(12):1031-1035.
Score: 0.476
-
Lisk C, McCord J, Bose S, Sullivan T, Loomis Z, Nozik-Grayck E, Schroeder T, Hamilton K, Irwin DC. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med. 2013 Oct; 63:264-73.
Score: 0.373
-
Irwin DC, Patot MT, Tucker A, Bowen R. Neutral endopeptidase null mice are less susceptible to high altitude-induced pulmonary vascular leak. High Alt Med Biol. 2005; 6(4):311-9.
Score: 0.208
-
Irwin DC, Rhodes J, Baker DC, Nelson SE, Tucker A. Atrial natriuretic peptide blockade exacerbates high altitude pulmonary edema in endotoxin-primed rats. High Alt Med Biol. 2001; 2(3):349-60.
Score: 0.158